In recent years, Johns Hopkins has been one of the leading research institutions exploring a class of drugs that were once considered taboo–namely psychedelics and hallucinogens. The Canadian Medical Association Journal recently analyzed a number of studies looking at psychedelic research at Hopkins and elsewhere. They found that the drugs show remarkable promise, and recommend that research should be increased.
Tag: magic mushrooms
Only a few medical/research facilities in the country have the official clearance to do research on psilocybin, a.k.a. magic mushrooms, a Schedule I drug. Johns Hopkins is one of those authorized to do those experiments, and some of its findings have been amazing–mushrooms have been shown to ease cancer patients’ anxiety about death and help people access profound spiritual experiences. And now new research out of Hopkins indicates that a dose of psilocybin can help longtime smokers finally give up the nicotine habit once and for all.